Company Filing History:
Years Active: 2013
Title: Innovations by Jianxin Gao in Inhalation Delivery Systems.
Introduction
Jianxin Gao is an accomplished inventor based in Norton, MA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of inhalation delivery systems. His innovative work focuses on improving the efficacy and safety of drug delivery methods.
Latest Patents
Jianxin Gao holds a patent for a "Stable epinephrine suspension formulation with high inhalation delivery efficiency." This patent describes a stable suspension aerosol formulation of epinephrine that is suitable for administration through inhalation. The formulation comprises a therapeutically effective amount of epinephrine, hydrofluorocarbon propellant, co-solvent, surfactant, and antioxidant. The formulation further includes pre-micronized epinephrine suspended in an alcohol/surfactant solution with hydrofluoroalkane propellant. This innovative suspension formulation provides a highly efficient delivery of drug microparticles into the respirable region of patients' lungs. It offers several advantages, including lower dosage requirements, minimum alcohol content, reduced impurities during storage, improved efficacy and safety, and no ozone-depleting potential compared to formulations containing chlorofluorocarbon.
Career Highlights
Jianxin Gao is currently associated with Amphastar Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has been instrumental in creating formulations that enhance patient outcomes and streamline drug delivery processes.
Collaborations
Jianxin Gao collaborates with notable colleagues, including James Luo and Rong Zhou. Their combined expertise contributes to the innovative projects at Amphastar Pharmaceuticals, Inc.
Conclusion
Jianxin Gao's contributions to inhalation delivery systems exemplify the importance of innovation in pharmaceutical science. His patent for a stable epinephrine suspension formulation highlights his commitment to improving drug delivery methods for better patient care.